Fresenius Medical Care AG & Co. KGaA (FMS)
NYSE: FMS · IEX Real-Time Price · USD
19.67
+0.44 (2.29%)
Jul 5, 2024, 4:00 PM EDT - Market closed
FMS Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for FMS stock has a target of 24, which predicts an increase of 22.01% from the current stock price of 19.67.
Analyst Consensus: Hold
* Price targets were last updated on May 15, 2024.
Analyst Ratings
The average analyst rating for FMS stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $21 → $24 | Hold | Maintains | $21 → $24 | +22.01% | May 15, 2024 |
| HSBC | HSBC | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Nov 24, 2023 |
| Truist Securities | Truist Securities | Hold Maintains $28 → $24 | Hold | Maintains | $28 → $24 | +22.01% | Oct 11, 2023 |
| Truist Securities | Truist Securities | Hold Maintains $26 → $28 | Hold | Maintains | $26 → $28 | +42.35% | Jul 13, 2023 |
| Truist Securities | Truist Securities | Hold Maintains $24 → $26 | Hold | Maintains | $24 → $26 | +32.18% | May 10, 2023 |
Financial Forecast
Revenue This Year
19.81B
from 19.45B
Increased by 1.85%
Revenue Next Year
20.58B
from 19.81B
Increased by 3.86%
EPS This Year
2.82
from 0.85
Increased by 232.29%
EPS Next Year
3.54
from 2.82
Increased by 25.41%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 21.1B | 21.9B | 23.2B | 25.1B | 25.3B |
| Avg | 19.8B | 20.6B | 21.4B | 22.9B | 23.5B |
| Low | 18.8B | 19.1B | 19.9B | 21.3B | 21.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.3% | 10.5% | 12.7% | 17.0% | 10.3% |
| Avg | 1.9% | 3.9% | 4.1% | 7.1% | 2.5% |
| Low | -3.5% | -3.4% | -3.5% | -0.6% | -4.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.43 | 4.67 | 6.13 | 6.97 | 5.88 |
| Avg | 2.82 | 3.54 | 4.12 | 5.04 | 5.22 |
| Low | 1.93 | 2.64 | 3.18 | 3.73 | 3.93 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 303.9% | 65.4% | 73.1% | 69.1% | 16.6% |
| Avg | 232.3% | 25.4% | 16.4% | 22.2% | 3.7% |
| Low | 127.1% | -6.7% | -10.4% | -9.4% | -22.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.